Cargando…

Basal cytokines profile in metastatic renal cell carcinoma patients treated with subcutaneous IL-2-based therapy compared with that of healthy donors

BACKGROUND AND PURPOSE: Metastatic renal cell carcinoma (MRCC) has a poor prognosis with a median overall survival of about one year. Since only a minority of patients experienced therapeutic benefit to current treatments, several studies have attempted to identify factors that may have an impact on...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guida, Michele, Casamassima, Addolorata, Monticelli, Giulia, Quaranta, Michele, Colucci, Giuseppe
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2007
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2169206/ https://www.ncbi.nlm.nih.gov/pubmed/17953739 http://dx.doi.org/10.1186/1479-5876-5-51

Ejemplares similares

Treatment of metastatic renal cell carcinoma with subcutaneous interleukin 2: evidence for non-renal clearance of cytokines.
por: Banks, R. E., et al.
Publicado: (1997)

Fibrinogen: a novel predictor of responsiveness in metastatic melanoma patients treated with bio-chemotherapy: IMI (italian melanoma inter-group) trial
por: Guida, Michele, et al.
Publicado: (2003)

High activity of sequential low dose chemo-modulating Temozolomide in combination with Fotemustine in metastatic melanoma. A feasibility study
por: Guida, Michele, et al.
Publicado: (2010)

Epratuzumab inhibits the production of the proinflammatory cytokines IL-6 and TNF-α, but not the regulatory cytokine IL-10, by B cells from healthy donors and SLE patients
por: Fleischer, Vanessa, et al.
Publicado: (2015)

Safety and efficacy of subcutaneous and continuous intravenous infusion rIL-2 in patients with metastatic renal cell carcinoma
por: Geertsen, P F, et al.
Publicado: (2004)

Metastatic renal cell carcinoma presenting as subcutaneous nodule()
por: Haque, Kabiul, et al.
Publicado: (2022)

Induction of IL-9 in Peripheral Lymphocytes of Rheumatoid Arthritis Patients and Healthy Donors by Th17-Inducing Cytokine Conditions
por: Heim, Jana, et al.
Publicado: (2021)

A Rare Subcutaneous Manifestation of Metastatic Renal Cell Carcinoma
por: Chan, Darren Yak Leong, et al.
Publicado: (2016)

In vivo stimulation of IL-12 secretion by subcutaneous low-dose IL-2 in metastatic cancer patients.
por: Lissoni, P., et al.
Publicado: (1998)

IL-6 Autoantibodies Predict Lower Platelet Counts and Altered Plasma Cytokine Profiles in Healthy Blood Donors: Results From the Danish Blood Donor Study
por: von Stemann, Jakob Hjorth, et al.
Publicado: (2022)

Immunotherapy with concurrent subcutaneous GM-CSF, low-dose IL-2 and IFN-α in patients with progressive metastatic renal cell carcinoma
por: Verra, N, et al.
Publicado: (2003)

Auto-Rejection of Renal Donor-Origin Metastatic Melanoma
por: Kriegshauser, J. Scott, et al.
Publicado: (2015)

Biology of Metastatic Renal Cell Carcinoma
por: Milella, Michele, et al.
Publicado: (2011)

Simultaneous Analysis of Cytokines and Costimulatory Molecules Concentrations by ELISA Technique and of Probabilities of Measurable Concentrations of Interleukins IL-2, IL-4, IL-5, IL-6, CXCL8 (IL-8), IL-10, IL-13 Occurring in Plasma of Healthy Blood Donors
por: Martin, Klabusay, et al.
Publicado: (2006)

Overview of Subcutaneous Metastatic Melanoma
por: Mozzillo, Nicola
Publicado: (2021)

Long-term renal and cardiovascular outcome of living kidney donors: A single-center retrospective observation study
por: Colucci, Vincenza, et al.
Publicado: (2022)

Expression of IL-23/Th17-related cytokines in basal cell carcinoma and in the response to medical treatments
por: Pellegrini, Cristina, et al.
Publicado: (2017)

Antitumor Effect of Cabozantinib in Bone Metastatic Models of Renal Cell Carcinoma
por: Iuliani, Michele, et al.
Publicado: (2021)

Subcutaneous Sarcoidal Granuloma Underlying Superficial Basal Cell Carcinoma
por: Ishikawa, Masato, et al.
Publicado: (2015)

Lifestyle and Dietary Habits Affect Plasma Levels of Specific Cytokines in Healthy Subjects
por: D'Esposito, Vittoria, et al.
Publicado: (2022)

Subcutaneous Emphysema as a Life-Threatening Complication of Metastatic Renal Cancer: A Case Report
por: GAMBUTI, EDOARDO, et al.
Publicado: (2021)

αβ-Double Negative CD4/CD8 (CD56) T cell (DNTs) in metastatic melanoma: basal frequency and behaviour during Ipilimumab treatment. Preliminary evaluations
por: De Tullio, Giacoma, et al.
Publicado: (2015)

Donor/Recipient Delta Age: A Possible Risk for Arterial Stenosis in Renal Transplantation
por: Pallotti, Giovanni, et al.
Publicado: (2015)

Leptin and fractalkine: novel subcutaneous cytokines in burn injury
por: Friston, Dominic, et al.
Publicado: (2020)

Abscopal responses in patients with metastatic melanoma involving skin and subcutaneous tissues treated with intralesional IL2 plus BCG
por: Vidovic, Dejan, et al.
Publicado: (2023)

Subcutaneous low-dose recombinant interleukin 2 and alpha-interferon in patients with metastatic renal cell carcinoma.
por: Ravaud, A., et al.
Publicado: (1994)

Exploring variability in basal ganglia connectivity with functional MRI in healthy aging
por: Griffanti, Ludovica, et al.
Publicado: (2018)

Association of Single Nucleotide Polymorphisms in the IL-18 Gene with Production of IL-18 Protein by Mononuclear Cells from Healthy Donors
por: Khripko, O. P., et al.
Publicado: (2008)

Comparative Evaluation of IFNγ, IL4 and IL17 Cytokines in Healthy Gingiva and Moderate to Advanced Chronic Periodontitis
por: Behfarnia, Parichehr, et al.
Publicado: (2010)

Metastatic Basal Cell Carcinoma: A Biological Continuum of Basal Cell Carcinoma?
por: Mehta, Karaninder S., et al.
Publicado: (2012)

Establishing the upper reference limit of Galectin-3 in healthy blood donors
por: Agnello, Luisa, et al.
Publicado: (2017)

Proteomic Profile and In Silico Analysis in Metastatic Melanoma with and without BRAF Mutation
por: Garrisi, Vito Michele, et al.
Publicado: (2014)

Checkpoint Inhibitors Immunotherapy in Metastatic Melanoma: When to Stop Treatment?
por: De Risi, Ivana, et al.
Publicado: (2022)

The reference liver—CYP450 and UGT enzymes in healthy donor and metastatic livers: the impact of genotype
por: Kurzawski, Mateusz, et al.
Publicado: (2021)

Phase I clinical trial with IL-2-transfected xenogeneic cells administered in subcutaneous metastatic tumours: clinical and immunological findings
por: Tartour, E, et al.
Publicado: (2000)

Expression of IL-1 family members upon stimulation with IL-17 differs in keratinocytes derived from psoriasis patients and healthy donors
por: Muhr, P, et al.
Publicado: (2010)

Bayesian modeling suggests that IL-12 (p40), IL-13 and MCP-1 drive murine cytokine networks in vivo
por: Field, Sarah L., et al.
Publicado: (2015)

Subcutaneous Fat Obesity in a High Body Mass Index Donor Is Not a Contraindication to Living Donor Hepatectomy
por: Pahari, Hirak, et al.
Publicado: (2023)

Primary Basal Cell Carcinoma Masquerading as Metastatic Basal Cell Carcinoma in the Left Axilla
por: Haskell Hanisch, Brianne, et al.
Publicado: (2023)

The Effect of IL-4 Gene Polymorphisms on Cytokine Production in Patients with Chronic Periodontitis and in Healthy Controls
por: Bartova, Jirina, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_6qcj82s86ves3dejsijikhduct